These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19116775)

  • 21. Mouse Strain Impacts Fatty Acid Uptake and Trafficking in Liver, Heart, and Brain: A Comparison of C57BL/6 and Swiss Webster Mice.
    Seeger DR; Murphy EJ
    Lipids; 2016 May; 51(5):549-60. PubMed ID: 26797754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-chain acyl-CoA synthetase 6 regulates lipid synthesis and mitochondrial oxidative capacity in human and rat skeletal muscle.
    Teodoro BG; Sampaio IH; Bomfim LH; Queiroz AL; Silveira LR; Souza AO; Fernandes AM; Eberlin MN; Huang TY; Zheng D; Neufer PD; Cortright RN; Alberici LC
    J Physiol; 2017 Feb; 595(3):677-693. PubMed ID: 27647415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Very long-chain acyl-CoA synthetases. Human "bubblegum" represents a new family of proteins capable of activating very long-chain fatty acids.
    Steinberg SJ; Morgenthaler J; Heinzer AK; Smith KD; Watkins PA
    J Biol Chem; 2000 Nov; 275(45):35162-9. PubMed ID: 10954726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease.
    Uehara T; Choong CJ; Nakamori M; Hayakawa H; Nishiyama K; Kasahara Y; Baba K; Nagata T; Yokota T; Tsuda H; Obika S; Mochizuki H
    Sci Rep; 2019 May; 9(1):7567. PubMed ID: 31110191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methamphetamine persistently increases alpha-synuclein and suppresses gene promoter methylation within striatal neurons.
    Biagioni F; Ferese R; Limanaqi F; Madonna M; Lenzi P; Gambardella S; Fornai F
    Brain Res; 2019 Sep; 1719():157-175. PubMed ID: 31150652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes.
    Du RH; Zhou Y; Xia ML; Lu M; Ding JH; Hu G
    J Neuroinflammation; 2018 Sep; 15(1):258. PubMed ID: 30200997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
    Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
    Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain astrocyte synthesis of docosahexaenoic acid from n-3 fatty acids is limited at the elongation of docosapentaenoic acid.
    Innis SM; Dyer RA
    J Lipid Res; 2002 Sep; 43(9):1529-36. PubMed ID: 12235185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triacsin C blocks de novo synthesis of glycerolipids and cholesterol esters but not recycling of fatty acid into phospholipid: evidence for functionally separate pools of acyl-CoA.
    Igal RA; Wang P; Coleman RA
    Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):529-34. PubMed ID: 9182714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippocampal alpha-synuclein mediates depressive-like behaviors.
    Du T; Li G; Luo H; Pan Y; Xu Q; Ma K
    Brain Behav Immun; 2021 Jul; 95():226-237. PubMed ID: 33775831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased Expression of the Multimerin-1 Gene in α-Synuclein Knokout Mice.
    Chaprov KD; Goloborshcheva VV; Tarasova TV; Teterina EV; Korokin MV; Soldatov VO; Pokrovskiy MV; Kucheryanu VG; Morozov SG; Ovchinnikov RK
    Dokl Biol Sci; 2020 Sep; 494(1):260-263. PubMed ID: 33083886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation levels of α-synuclein intron 1 in the aging brain.
    de Boni L; Riedel L; Schmitt I; Kraus TFJ; Kaut O; Piston D; Akbarian S; Wüllner U
    Neurobiol Aging; 2015 Dec; 36(12):3334.e7-3334.e11. PubMed ID: 26422361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatty acid transport protein 4 is the principal very long chain fatty acyl-CoA synthetase in skin fibroblasts.
    Jia Z; Moulson CL; Pei Z; Miner JH; Watkins PA
    J Biol Chem; 2007 Jul; 282(28):20573-83. PubMed ID: 17522045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid metabolism alterations in the neuronal response to A53T α-synuclein and Fe-induced injury.
    Sánchez Campos S; Alza NP; Salvador GA
    Arch Biochem Biophys; 2018 Oct; 655():43-54. PubMed ID: 30098984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
    Rutherford NJ; Moore BD; Golde TE; Giasson BI
    J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course.
    Tayebi N; Parisiadou L; Berhe B; Gonzalez AN; Serra-Vinardell J; Tamargo RJ; Maniwang E; Sorrentino Z; Fujiwara H; Grey RJ; Hassan S; Blech-Hermoni YN; Chen C; McGlinchey R; Makariou-Pikis C; Brooks M; Ginns EI; Ory DS; Giasson BI; Sidransky E
    Mol Genet Metab; 2017 Dec; 122(4):198-208. PubMed ID: 29173981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of α-synuclein expression in cultured cortical neurons.
    Clough RL; Dermentzaki G; Haritou M; Petsakou A; Stefanis L
    J Neurochem; 2011 Apr; 117(2):275-85. PubMed ID: 21272005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
    Hong CT; Chen KY; Wang W; Chiu JY; Wu D; Chao TY; Hu CJ; Chau KD; Bamodu OA
    Cells; 2020 Mar; 9(3):. PubMed ID: 32192190
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson's disease management.
    Sola P; Krishnamurthy P; Chintamaneni PK; Pindiprolu SKSS; Kumari M
    Expert Opin Drug Deliv; 2020 Aug; 17(8):1119-1132. PubMed ID: 32497457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.